93 5514 93 5514 Pill - green black capsule/oblong, 22mm
Pill with imprint 93 5514 93 5514 is Green / Black, Capsule/Oblong and has been identified as Carbamazepine Extended-Release 300 mg. It is supplied by Teva Pharmaceuticals USA Inc.
Carbamazepine is used in the treatment of Trigeminal Neuralgia; Schizoaffective Disorder; Bipolar Disorder; Epilepsy and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 5514 93 5514
Carbamazepine Extended-Release
- Imprint
- 93 5514 93 5514
- Strength
- 300 mg
- Color
- Green / Black
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Dibenzazepine anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC)
- 00093-5514 (Discontinued)
- Inactive Ingredients
-
carnauba wax,
D&C Yellow No. 10,
aluminum oxide,
FD&C Green No. 3,
gelatin,
ferrosoferric oxide,
lactose monohydrate,
polyethylene glycol 1450,
polyethylene glycol (PEG) 4500,
propylene glycol,
shellac,
sodium lauryl sulfate,
sorbitan monolaurate,
titanium dioxide,
povidone,
sodium hydroxide
Note: Inactive ingredients may vary.
More about carbamazepine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (342)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: dibenzazepine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Carbamazepine drug information
- Carbamazepine (Intravenous) (Advanced Reading)
- Carbamazepine (Oral) (Advanced Reading)
- Carbamazepine Chewable Tablets
- Carbamazepine Extended-Release Capsules (Carbatrol)
Other brands
Tegretol, Carbatrol, Tegretol XR, Equetro, ... +2 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.